Discover
HALO
Halozyme Therapeutics, Inc.
77.01
1 x 72.13
1 x 79.90
bid
ask
-
1.26
1.61%
1 @ 04:00 PM
77.35 +0.34 (0.44%)
| Ytd | 14.43% | |
| 1y | 45.52% |
75.71
day range
78.49
52.72
52 week range
82.22
| Open | 78.49 | Prev Close | 78.27 | Low | 75.71 | High | 78.49 | Mkt Cap | 9.13B |
| Vol | 1.59M | Avg Vol | 1.72M | EPS | 2.85 | P/E | 27.02 | Forward P/E | 7.91 |
| Beta | 0.87 | Short Ratio | 7.53 | Inst. Own | 107.29% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 68.80 | 200-d Avg | 69.09 | 1yr Est | 83.90 |
| Income Statement | |||
| Total Revenue | 376.71M | ||
| Revenues (USD) | 376.71M | ||
| Cost of Revenue | 79.24M | ||
| Gross Profit | 297.47M | ||
| Operating Expenses | 112.95M | ||
| Research and Development Expense | 25.56M | ||
| Selling, General and Administrative Expense | 57.88M | ||
| Operating Income | 184.52M | ||
| Interest Expense | 5.51M | ||
| Income Tax Expense | 30.28M | ||
| Net Income | 150.05M | ||
| Net Income Common Stock | 150.05M | ||
| Net Income Common Stock (USD) | 150.05M | ||
| Consolidated Income | 150.05M | ||
| Earnings per Basic Share | 1.27 | ||
| Earnings per Basic Share (USD) | 1.27 | ||
| Earnings per Diluted Share | 1.22 | ||
| Earning Before Interest & Taxes (EBIT) | 185.84M | ||
| Earning Before Interest & Taxes (USD) | 185.84M | ||
| Weighted Average Shares | 118.14M | ||
| Weighted Average Shares Diluted | 122.88M | ||
| Balance Sheet | |||
| Cash and Equivalents | 312.01M | ||
| Cash and Equivalents (USD) | 312.01M | ||
| Investments | 8.87M | ||
| Investments Current | 8.87M | ||
| Trade and Non-Trade Receivables | 457.99M | ||
| Current Assets | 1.00B | ||
| Property, Plant & Equipment Net | 82.23M | ||
| Total Assets | 2.67B | ||
| Debt Current | 208.74M | ||
| Total Debt | 2.14B | ||
| Current Liabilities | 363.21M | ||
| Debt Non-Current | 1.94B | ||
| Total Liabilities | 2.45B | ||
| Accumulated Retained Earnings (Deficit) | 204.84M | ||
| Accumulated Other Comprehensive Income | -12.70M | ||
| Shareholders Equity | 219.64M | ||
| Shareholders Equity (USD) | 219.64M | ||
| Assets Non-Current | 1.67B | ||
| Total Debt (USD) | 2.14B | ||
| Goodwill and Intangible Assets | 1.53B | ||
| Inventory | 155.47M | ||
| Liabilities Non-Current | 2.09B | ||
| Trade and Non-Trade Payables | 14.10M | ||
| Tax Liabilities | 47.53M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 33.73M | ||
| Net Cash Flow from Financing | -1.61M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 175.59M | ||
| Capital Expenditure | -3.74M | ||
| Net Cash Flow - Business Acquisitions and Disposals | 710.00K | ||
| Net Cash Flow from Investing | -2.88M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 154.00K | ||
| Net Cash Flow from Operations | 180.08M | ||
| Share Based Compensation | 16.64M | ||